SciELO - Scientific Electronic Library Online

 
vol.58 issue6A comparative study between 25 × 0.70 mm and 20 × 0.55 mm needles for retrobulbar block with small volume of anesthetic for the treatment of cataracts by phacoemulsificationEffects of the addition of subarachnoid clonidine to the anesthetic solution of sufentanil and hyperbaric or hypobaric bupivacaine for labor analgesia author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Revista Brasileira de Anestesiologia

Print version ISSN 0034-7094

Abstract

BRAGA, Angélica de Fátima de Assunção et al. Neuromuscular and cardiovascular effects of pipecuronium: a comparative study between different dose. Rev. Bras. Anestesiol. [online]. 2008, vol.58, n.6, pp. 582-592. ISSN 0034-7094.  http://dx.doi.org/10.1590/S0034-70942008000600003.

BACKGROUND AND OBJECTIVES: Pipecuronium is a non-depolarizing neuromuscular blocker with similar properties to pancuronium, but without cardiovascular effects. Neuromuscular effects, conditions of tracheal intubation, and hemodynamic repercussions of two different doses of pipecuronium were evaluated. METHOD: Patients were divided into two groups according to the dose of pipecuronium: Group I (0.04 mg.kg-1) and Group II (0.05 mg.kg-1). Intramuscular midazolam (0.1 mg.kg-1) was administered 30 minutes before the surgery. Propofol (2.5 mg.kg-1), preceded by fentanyl (5 µg.kg-1) and pipecuronium (0.04 and 0.05 mg.kg-1 for Groups I and II, respectively), was administered for anesthetic induction. Patients were ventilated with 100% oxygen via a face mask until a 75% reduction in the amplitude of the response to an isolated stimulus (1 Hz) is achieved, at which time laryngoscopy and intubation were carried out. Anesthetic maintenance was achieved with isoflurane (0.5 to 1%) with a mixture of 50% O2 and N2O. Mechanical ventilation was used to maintain PETCO2 between 32 and 36 mmHg. The pharmacodynamics of pipecuronium was evaluated by acceleromyography. RESULTS: Mean times and standard deviation for the onset of action, clinical duration (T125%), and recovery index (T125-75%) were: Group I (122.10 ± 4.18 sec, 49.63 ± 9.54 min, and 48.21 ± 6.72 min), and Group II (95.78 ± 8.91 sec, 64.84 ± 13.13 min, and 48.52 ± 4.95 min). Onset of action, clinical duration, and conditions of tracheal intubation were significantly different for both groups. CONCLUSIONS: Pipecuronium at a dose of 0.05 mg.kg-1 can be used in prolonged procedures in which cardiovascular changes should be avoided.

Keywords : NEUROMUSCULAR BLOCKERS, Non-depolarizing [Pipecuronium]; PHARMACOLOGY [Pharmacodynamics]; PHARMACOLOGY [Pharmacokinetics].

        · abstract in Portuguese | Spanish     · text in English | Portuguese     · pdf in English | Portuguese